YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (1558.HK)
HKD 11.5
(0.0%)
HKD 11.5
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.29 Billion | 3.74 Billion | 913.78 Million | 2.34 Billion | 6.22 Billion | 2.51 Billion |
| Cost of Revenue | 1.3 Billion | 898.87 Million | 430.08 Million | 351.54 Million | 921.82 Million | 398.8 Million |
| Gross Profit | 4.98 Billion | 2.84 Billion | 483.69 Million | 1.99 Billion | 5.3 Billion | 2.11 Billion |
| Operating Expenses | 2.63 Billion | 2.53 Billion | 918.42 Million | 766.91 Million | 2.86 Billion | 1.02 Billion |
| Selling, General and Administrative Expenses | 1.93 Billion | 1.55 Billion | 883.24 Million | 1.46 Billion | 2.86 Billion | 1.03 Billion |
| Research and Development Expenses | 192.28 Million | 129.61 Million | 136.65 Million | 119.42 Million | 162.61 Million | 224.1 Million |
| Other Expenses | 499.8 Million | 172 Thousand | 60 Thousand | 255.19 Million | -4.6 Million | 5.5 Million |
| Cost and Expenses | 3.94 Billion | 3.43 Billion | 1.34 Billion | 1.11 Billion | 3.78 Billion | 1.42 Billion |
| Operating Income | 2.35 Billion | 322.72 Million | -458.1 Million | 833.69 Million | 2.52 Billion | 1.08 Billion |
| Interest Expense | 227.39 Million | 281.64 Million | 243.8 Million | 244.2 Million | 204.5 Million | 1.41 Million |
| Income Tax Expense | 270.94 Million | 9.81 Million | 79.46 Million | 173.02 Million | 361.86 Million | 201.1 Million |
| Earnings before Tax | 2.12 Billion | 39.42 Million | -667.18 Million | 1.01 Billion | 2.26 Billion | 1.1 Billion |
| Net Income | 1.99 Billion | 76.6 Million | -587.64 Million | 839.45 Million | 1.91 Billion | 942.53 Million |
| Earnings Per Share Basic | 2.26 | 0.09 | -0.67 | 0.95 | 2.16 | 1.04 |
| Earnings Per Share Diluted | 2.26 | 0.09 | -0.67 | 0.53 | 2.07 | 1.04 |
| Weighted Average Shares Outstanding | 879.96 Million | 879.96 Million | 877.08 Million | 1.1 Billion | 1 Billion | 904.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 879.96 Million | 879.96 Million | 879.96 Million | 1.1 Billion | 1 Billion | 904.04 Million |
| Gross Margin | 0.79 | 0.76 | 0.53 | 0.85 | 0.85 | 0.84 |
| EBIT Margin | 0.44 | 0.18 | -0.23 | 0.40 | 0.42 | 0.46 |
| Profit Margin | 0.32 | 0.02 | -0.64 | 0.36 | 0.31 | 0.38 |
| EBITDA | 2.74 Billion | 691.48 Million | -206.55 Million | 950.23 Million | 2.61 Billion | 1.14 Billion |
| Earnings Before Tax Margin | 0.37 | 0.09 | -0.50 | 0.36 | 0.41 | 0.43 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 2.45 Billion | 3.08 Billion | 6.29 Billion | 3.2 Billion | 3.74 Billion | 2.45 Billion |
| Cost of Revenue | 505.53 Million | 663.75 Million | 1.3 Billion | 645.06 Million | 898.87 Million | 566.22 Million |
| Gross Profit | 1.94 Billion | 2.42 Billion | 4.98 Billion | 2.56 Billion | 2.84 Billion | 1.88 Billion |
| Operating Expenses | 1.08 Billion | 1.46 Billion | 2.1 Billion | 1.19 Billion | 2.53 Billion | 1.66 Billion |
| Selling, General and Administrative Expenses | 878.79 Million | 1.01 Billion | - | 927.33 Million | - | 873.61 Million |
| Research and Development Expenses | 265.92 Million | 94.02 Million | - | 98.26 Million | - | 88.7 Million |
| Other Expenses | -62.87 Million | 359.58 Million | -1 Million | - | 172 Thousand | - |
| Cost and Expenses | 1.58 Billion | 2.12 Billion | 3.41 Billion | 1.84 Billion | 3.43 Billion | 2.23 Billion |
| Operating Income | 867.38 Million | 956.07 Million | 2.35 Billion | 1.48 Billion | 322.72 Million | 79.6 Million |
| Interest Expense | - | - | 227.39 Million | - | 281.64 Million | - |
| Income Tax Expense | 128.8 Million | 33.01 Million | 270.94 Million | 237.92 Million | 9.81 Million | 5.87 Million |
| Earnings before Tax | 813.53 Million | 864.91 Million | 2.12 Billion | 1.26 Billion | 39.42 Million | 75.82 Million |
| Net Income | 684.73 Million | 963.12 Million | 1.99 Billion | 1.02 Billion | 76.6 Million | 109.4 Million |
| Earnings Per Share Basic | 0.78 | 1.09 | - | 1.17 | - | 0.12 |
| Earnings Per Share Diluted | 0.78 | 1.09 | - | 1.17 | - | 0.12 |
| Weighted Average Shares Outstanding | 879.96 Million | 883.6 Million | 879.96 Million | 879.96 Million | 879.96 Million | 879.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 879.96 Million | 879.96 Million | 879.96 Million | 879.96 Million | 879.96 Million | 879.96 Million |
| Gross Margin | 0.79 | 0.78 | 0.79 | 0.80 | 0.76 | 0.77 |
| EBIT Margin | 3.67 | 0.49 | - | 0.52 | - | 0.11 |
| Profit Margin | 0.28 | 0.31 | 0.32 | 0.32 | 0.02 | 0.04 |
| EBITDA | 9 Billion | 1.49 Billion | - | 1.67 Billion | - | 274.3 Million |
| Earnings Before Tax Margin | 0.35 | 0.31 | 0.37 | 0.46 | 0.09 | 0.03 |
SIE
AMFC
VRS
ASTA
ALGIR
ASLE